MedPharm appoints Jason Mieding as chief operating officer
Corporate, Pharmacy, manufacturing, pharmaceutical
MedPharm has appointed Jason Mieding as chief operating officer (COO), a newly created role reflecting the company’s growth over the …
UKRI backs five hubs developing AI tools for earlier disease detection
November 8, 2026Cardiology, Devices, Haematology, Infections and infestations, Neurology, Psychiatry, R&D, Wound Healing, community health, community healthcare, medical technology
Five UK research hubs are to receive more than £52m in government funding to develop technologies aimed at detecting disease …
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026Corporate, biopharmaceutical manufacturing
Coriolis Pharma has appointed Dr Teun van der Heide as chief executive officer, effective 2 November 2026. Van der Heide …
NEC joins €6.5m European project using AI for pandemic vaccine design
November 6, 2026EU, Immunology, Infections and infestations, Pharmacy, Vaccine, collaboration, pandemic
NEC OncoImmunity, a subsidiary of NEC Corporation, is leading the AI-powered antigen prediction and vaccine design work in a four-year …
The evidence bar impacting UK medical cannabis access
November 6, 2026Cannabinoids, Chronic Diseases, Legislation, NICE, Pharmacy, chronic pain, drug approval
By Mike Morgan-Giles Private prescribing of cannabis-based medicines in the UK has more than doubled in a year. Getting the …
Survey highlights mental health burden among rare disease patients and families
November 5, 2026Psychiatry, Rare Diseases, neurology, rare disease, survey
Seven in 10 people affected by rare diseases, including patients and family members, report poor mental health, according to a …
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026Pain, Rheumatology, autoimmune disease, diagnostic tests, peptides, primary care, rheumatoid arthritis
By Tara Bruner Autoimmune diseases affect more than 15 million people [1] in the U.S. alone yet remain chronically underdiagnosed. …
Five Facts about medicinal cannabis and chronic disease
November 4, 2026Medical Communications Chronic Diseases, Five Facts, Pain, Smoking Cessation, chronic disease, medicinal cannabis
1 Chronic pain is generally defined as pain that persists or recurs for more than three months. It can arise …
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
November 4, 2026Asthma & COPD, Cardiology, Corporate, Diabetes, LDTs, Neurology, Oncology, Osteoporosis, Skin, biomarkers, chronic disease, chronic pain, genetic testing, healthcare innovation, investment
As healthcare budgets become increasingly stretched by the demands of coping with long-term illnesses, interest is growing in the manufacturing …
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026Cardiology, EnteroBiotix, GSK, Obesity, Pharmacy, appointments, approvals
EnteroBiotix has appointed Dr Murray Stewart, former Chief Medical Officer at GSK and Rhythm Pharmaceuticals, to its Board of Directors. …
Stryker invests US$400m in CMR Surgical and secures option to acquire business
November 3, 2026Devices, acquisitions, healthcare market, investment, medical technology
US medical technology company Stryker is investing approximately US$400m (£300m) in UK surgical robotics developer CMR Surgical, alongside securing an …
AI: an early warning system for patient safety
November 3, 2026AI, Cardiology, Diabetes, Diagnostics, Obesity, Pharmacy, chronic disease, chronic pain, pharmacovigilance
By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While every medicine undergoes rigorous clinical …
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
November 2, 2026Gastrointestinal tract, clinical trial, drug delivery, gastrointestinal, inflammation
AstraZeneca and Amgen’s Tezspire (tezepelumab) has demonstrated significant improvements in tissue inflammation and swallowing symptoms in patients with eosinophilic oesophagitis …
Highlighting the value of lab research for healthcare innovation
November 2, 2026Cardiology, Devices, Neurology, Oncology, diagnostic tests, healthcare innovation, laboratory science, neurodegenerative disease, oncology
Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory Day. Staged by the European …
Capital Dynamics invests €14m in Italian community healthcare platform CareHub
October 30, 2026Corporate, Diagnostics, Hospital Management, community healthcare, nline platforms, private equity
Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity fund Silver …
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026Cardiology, Devices, Oncology, cardiology, medical devices
Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for patients who …
Dermatology leader Doncker is new Onicor CEO
October 29, 2026Dermatology, Infections and infestations, appointments, fungal infection
Onicor, a medical technology company developing a personalised treatment for onychomycosis (fungal nail infection), has appointed Piet De Doncker as …
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
October 29, 2026Cardiology, Chronic Diseases, Hospital Management, NICE, cardiology, cholesterol, community healthcare, pharmacies
A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access treatment sooner and …
Weber is new CMO at Sensorion
October 28, 2026Ear Nose & throat, Genetic disorders, Neurology, hearing loss
Otologist and neurotologist Dr. Peter Weber has been appointed Chief Medical Officer of biotech Sensorion. The company, which develops novel …
Charity commits £800,000 to AI research into late breast cancer recurrence
October 28, 2026AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
October 27, 2026Asthma & COPD, COPD, EMA, EU, Pharmacy, asthma
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European Commission as a maintenance treatment for asthma in …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
